BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1619 related articles for article (PubMed ID: 12365081)

  • 1. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparison of the management of severe high blood pressure between 1999 and 2003 in France].
    Bertin N; Salanave B; Tilly B; Guilhot J; Ricordeau P; Fender P; Dematons MN; Treppoz H; Allemand H
    Arch Mal Coeur Vaiss; 2004; 97(7-8):793-8. PubMed ID: 15506068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Evaluation and stratification of cardiovascular risk based on the 2000 ANAES recommendations in a population of hypertensive patients].
    Mounier-Vehier C; Amah G; Covillard J; Jaboureck O; Phan TM
    Arch Mal Coeur Vaiss; 2002; 95(7-8):667-72. PubMed ID: 12365077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in life style and drug therapy for treatment of hypertension in France between 2002 and 2004].
    Girerd X; Herpin D; Postel-Vinay N; Vaïsse B; Poncelet P; Mallion JM; Murino M; Mourad JJ
    Arch Mal Coeur Vaiss; 2005; 98(7-8):813-6. PubMed ID: 16220753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study].
    Mallion JM; Kahn JC; Poncelet P; Pannier B; Vaïsse B; Koch C; Phan TM; Pithois-Merli I
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):834-8. PubMed ID: 11575213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of control of high blood pressure and treatment recommendations in Canada.
    Khan N; Chockalingam A; Campbell NR
    Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994].
    Poggi L; Chamontin B; Lang T; Menard J; Chevalier H; Gallois H; Cremier O
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the "Health Program Hypertension" of the German Health Insurance (DKV)].
    Lickvers K; Kottmair S; Rose I; Müller M; Middeke M
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2628-30. PubMed ID: 16281157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aterial hypertension and cardiovascular risk factors associated with diabetes. Report of the PHARE survey in general practice].
    Chamontin B; Lang T; Vaisse B; Nicodeme R; Antoine MP; Lazorthes ML; Gallois H; Poggi L
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):869-73. PubMed ID: 11575221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T; Eon Y; Le Néel H; Seignard H; Battini J
    Arch Mal Coeur Vaiss; 2005; 98(7-8):761-6. PubMed ID: 16220744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
    Hanon O; Hoguin JC; Girerd X
    Arch Mal Coeur Vaiss; 2003; 96(7-8):744-7. PubMed ID: 12945215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.